Clinical Trial Update: Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 trial evaluating Samarium Sm-153 lexidronam with zoledronic acid or pamidronate for relapsed/refractory multiple myeloma with bone pain has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Pain
• Multiple Myeloma

Drugs mentioned

• Pamidronate (pamidronate disodium)
• Samarium Sm-153 lexidronam pentasodium (samarium-153 lexidronam)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Mayo Clinic | Conditions: Multiple Myeloma and Plasma Cell Neoplasm, Pain | Phase 1, Phase 2 | Status: COMPLETED